247 related articles for article (PubMed ID: 7248445)
1. Sequential clinical trials for normal variates using interval composite hypotheses.
Lachin JM
Biometrics; 1981 Mar; 37(1):87-101. PubMed ID: 7248445
[TBL] [Abstract][Full Text] [Related]
2. A Bayesian stopping rule for a single arm study: With a case study of stem cell transplantation.
Chen C; Chaloner K
Stat Med; 2006 Sep; 25(17):2956-66. PubMed ID: 16345039
[TBL] [Abstract][Full Text] [Related]
3. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
Sebille V; Bellissant E
Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
[TBL] [Abstract][Full Text] [Related]
4. One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach.
Berry DA; Ho CH
Biometrics; 1988 Mar; 44(1):219-27. PubMed ID: 3358990
[TBL] [Abstract][Full Text] [Related]
5. A Bayesian approach to bioequivalence for the 2 x 2 changeover design.
Selwyn MR; Dempster AP; Hall NR
Biometrics; 1981 Mar; 37(1):11-21. PubMed ID: 7018605
[TBL] [Abstract][Full Text] [Related]
6. Early stopping for sequential restricted tests of binomial distributions.
Dambrosia JM; Greenhouse SW
Biometrics; 1983 Sep; 39(3):695-710. PubMed ID: 6652203
[TBL] [Abstract][Full Text] [Related]
7. Non-inferiority trials: the 'at least as good as' criterion.
Laster LL; Johnson MF
Stat Med; 2003 Jan; 22(2):187-200. PubMed ID: 12520556
[TBL] [Abstract][Full Text] [Related]
8. Early stopping rules in clinical trials based on sequential monitoring of serious adverse events.
Kramar A; Bascoul-Mollevi C
Med Decis Making; 2009; 29(3):343-50. PubMed ID: 19073996
[TBL] [Abstract][Full Text] [Related]
9. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.
Daimon T
Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944
[TBL] [Abstract][Full Text] [Related]
10. Predictive probability early termination plans for phase II clinical trials.
Herson J
Biometrics; 1979 Dec; 35(4):775-83. PubMed ID: 526523
[TBL] [Abstract][Full Text] [Related]
11. Implementing type I & type II error spending for two-sided group sequential designs.
Rudser KD; Emerson SS
Contemp Clin Trials; 2008 May; 29(3):351-8. PubMed ID: 17933592
[TBL] [Abstract][Full Text] [Related]
12. Bayesian design of single-arm phase II clinical trials with continuous monitoring.
Johnson VE; Cook JD
Clin Trials; 2009 Jun; 6(3):217-26. PubMed ID: 19528131
[TBL] [Abstract][Full Text] [Related]
13. Symmetric group sequential test designs.
Emerson SS; Fleming TR
Biometrics; 1989 Sep; 45(3):905-23. PubMed ID: 2675998
[TBL] [Abstract][Full Text] [Related]
14. Design and analysis of group sequential logrank tests in maximum duration versus information trials.
Kim K; Boucher H; Tsiatis AA
Biometrics; 1995 Sep; 51(3):988-1000. PubMed ID: 7548714
[TBL] [Abstract][Full Text] [Related]
15. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
16. Sequential allocation in clinical trials comparing two exponential survival curves.
Louis TA
Biometrics; 1977 Dec; 33(4):627-34. PubMed ID: 338043
[TBL] [Abstract][Full Text] [Related]
17. Continuous toxicity monitoring in phase II trials in oncology.
Ivanova A; Qaqish BF; Schell MJ
Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
[TBL] [Abstract][Full Text] [Related]
18. An analysis of the controversy over classical one-sided tests.
Freedman LS
Clin Trials; 2008; 5(6):635-40. PubMed ID: 19029216
[TBL] [Abstract][Full Text] [Related]
19. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
Zhao Y; Grambsch PM; Neaton JD
Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
[TBL] [Abstract][Full Text] [Related]
20. Confidence intervals for a ratio of two independent binomial proportions.
Price RM; Bonett DG
Stat Med; 2008 Nov; 27(26):5497-508. PubMed ID: 18781560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
